These two proteins (FGA and APP) might have diagnostic potential in AD from blood, and there are different examination methods available for the utilization of FGA and APP as biomarkers (Irizarry, 2004; Joung Wook et al., 2007; Cortes-Canteli et al., 2012). This evidence concerns the gene FGA and Alzheimer disease.